$125 | Single User
$250 | Site License
$375 | Enterprise License

Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review

Published by Global Data: 24 May 2016 | 12249 | In Stock

Introduction

Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Interleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include PerioPredict genetic risk test; Weight management genetic test; Bone health genetic test; Heart health genetic test; Nutritional needs genetic test; and Wellness select genetic test. PerioPredict genetic test analyzes genetic variations that are associated with inflammation and helps in identifying individuals who are at increased risk for severe periodontal disease. Its genetic test product pipeline includes IL-1 genetic test for cardiovascular disease and osteoarthritis genetic test for osteoarthritis (OA). The company distributes its products through partnership with healthcare professionals, health and wellness companies, and distribution channels. Interleukin is headquartered in Waltham, Massachusetts, the US.

Interleukin Genetics, Inc. Key Recent Developments

May 16, 2016: Interleukin Genetics Reports First Quarter 2016 Financial Results

Mar 17, 2016: Interleukin Genetics Reports Fourth Quarter and Year-End 2015 Financial Results

Mar 16, 2016: Interleukin Genetics Appoints Global Clinical Advisory Board To Guide Enhanced Healthcare through Targeted Management of Systemic Inflammation

Nov 12, 2015: Interleukin Genetics Reports Third Quarter 2015 Financial Results

Aug 14, 2015: Interleukin Genetics Reports Second Quarter 2015 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Section 1 - About the Company 6

    Interleukin Genetics, Inc. - Key Facts 6

    Interleukin Genetics, Inc. - Key Employees 7

    Interleukin Genetics, Inc. - Key Employee Biographies 8

    Interleukin Genetics, Inc. - Major Products and Services 9

    Interleukin Genetics, Inc. - Medical Equipment Pipeline Products Data 10

    Interleukin Genetics, Inc. Pipeline Products by Equipment Type 10

    Interleukin Genetics, Inc. Pipeline Products by Development Stage 12

    Interleukin Genetics, Inc. - History 14

    Interleukin Genetics, Inc. - Company Statement 17

    Interleukin Genetics, Inc. - Locations And Subsidiaries 19

    Head Office 19

    Section 2 – Company Analysis 20

    Interleukin Genetics, Inc. - Business Description 20

    Interleukin Genetics, Inc. - Corporate Strategy 21

    Interleukin Genetics, Inc. - SWOT Analysis 22

    SWOT Analysis - Overview 22

    Interleukin Genetics, Inc. - Strengths 22

    Strength - Research and Development Activities 22

    Strength - Strategic Collaborations 22

    Strength - Patent Portfolio 22

    Interleukin Genetics, Inc. - Weaknesses 23

    Weakness - Dependence on Significant Customers 23

    Weakness - History of Operating Losses 23

    Interleukin Genetics, Inc. - Opportunities 24

    Opportunity - Rising Healthcare Expenditure in the US 24

    Opportunity - Growing IVD Market 24

    Interleukin Genetics, Inc. - Threats 25

    Threat - Stiff Competition 25

    Threat - Risk of Product Obsolescence 25

    Threat - Stringent Government Regulations 25

    Interleukin Genetics, Inc. - Key Competitors 26

    Section 3 – Company Financial Ratios 27

    Financial Ratios - Capital Market Ratios 27

    Financial Ratios - Annual Ratios 28

    Performance Chart 29

    Financial Performance 29

    Financial Ratios - Ratio Charts 30

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 31

    Interleukin Genetics, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 31

    Interleukin Genetics, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 32

    Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 33

    Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 34

    Interleukin Genetics, Inc., Recent Deals Summary 35

    Section 5 – Company’s Recent Developments 36

    May 16, 2016: Interleukin Genetics Reports First Quarter 2016 Financial Results 36

    Mar 17, 2016: Interleukin Genetics Reports Fourth Quarter and Year-End 2015 Financial Results 38

    Mar 16, 2016: Interleukin Genetics Appoints Global Clinical Advisory Board To Guide Enhanced Healthcare through Targeted Management of Systemic Inflammation 40

    Nov 12, 2015: Interleukin Genetics Reports Third Quarter 2015 Financial Results 41

    Aug 14, 2015: Interleukin Genetics Reports Second Quarter 2015 Financial Results 43

    May 15, 2015: Interleukin Genetics Reports First Quarter 2015 Financial Results 45

    Apr 15, 2015: Interleukin Genetics Granted Key European Patent Covering Inherent Health Weight Management Genetic Test 47

    Apr 07, 2015: Interleukin Genetics Appoints Mark B. Carbeau as CEO 48

    Apr 01, 2015: Interleukin Genetics Collaborators Present Scientific Research Supporting Weight Management Genetic Test at the 2015 Experimental Biology Annual Meeting 49

    Mar 20, 2015: Interleukin Genetics Reports Fourth Quarter and Year-End 2014 Financial Results 50

    Section 6 – Appendix 52

    Methodology 52

    Ratio Definitions 52

    About GlobalData 56

    Contact Us 56

    Disclaimer 56

List Of Tables
in Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review

List of Tables

Interleukin Genetics, Inc., Key Facts 6

Interleukin Genetics, Inc., Key Employees 7

Interleukin Genetics, Inc., Key Employee Biographies 8

Interleukin Genetics, Inc., Major Products and Services 9

Interleukin Genetics, Inc. Number of Pipeline Products by Equipment Type 10

Interleukin Genetics, Inc. Pipeline Products by Equipment Type 11

Interleukin Genetics, Inc. Number of Pipeline Products by Development Stage 12

Interleukin Genetics, Inc. Pipeline Products by Development Stage 13

Interleukin Genetics, Inc., History 14

Interleukin Genetics, Inc., Key Competitors 26

Interleukin Genetics, Inc., Ratios based on current share price 27

Interleukin Genetics, Inc., Annual Ratios 28

Interleukin Genetics, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 31

Interleukin Genetics, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 32

Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 33

Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 34

Interleukin Genetics, Inc., Recent Deals Summary 35

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55

List Of Figures, Charts and Diagrams
in Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review

List of Figures

Interleukin Genetics, Inc. Pipeline Products by Equipment Type 10

Interleukin Genetics, Inc. Pipeline Products by Development Stage 12

Interleukin Genetics, Inc., Performance Chart (2011 - 2015) 29

Interleukin Genetics, Inc., Ratio Charts 30

Interleukin Genetics, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 31

Interleukin Genetics, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 32

Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 33

Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 34

Additional Details

Publisher

Global Data

Publisher Information

Reference

12249 | GDME15403FSA

Number of Pages

56

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016
Interleukin 12 Receptor (IL12R) - Pipeline Review, H2 2016SummaryGlobal Markets Direct’s, ‘Interleuk...
28 Dec 2016 by Global Markets Direct USD $3,500 More Info
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2016
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11....
21 Dec 2016 by Global Markets Direct USD $3,500 More Info
Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016
Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016SummaryGlobal Mark...
14 Dec 2016 by Global Markets Direct USD $3,500 More Info
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile
SummaryInterleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and ...
14 Nov 2016 by Global Data USD $250 More Info
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H2 2016
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H2 2016SummaryGlobal M...
09 Nov 2016 by Global Markets Direct USD $3,500 More Info
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile
SummaryInterleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company which develops an...
21 Jul 2016 by Global Data USD $250 More Info
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile
SummaryInterleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company. It develops and ...
02 May 2016 by Global Data USD $250 More Info
CEL-SCI Corporation (formerly Interleukin-2, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
Interleukin Genetics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and In...
10 Mar 2016 by Marketline USD $350 More Info
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile
SummaryInterleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company. It develops and ...
24 Feb 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data